BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-78@pharmaconomics
DTSTAMP:20260707T014612Z
DTSTART;VALUE=DATE:20261123
DTEND;VALUE=DATE:20261124
SUMMARY:GSK Phase 3 — Investigational varicella vaccine
DESCRIPTION:Phase 3 trial results for Investigational varicella vaccine in Chickenpox are due Nov 23\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://clinicaltrials.gov/study/NCT06693895\n\nTrack it: https://pharmaconomics.com/e/78
URL:https://pharmaconomics.com/e/78
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:GSK catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR